论文部分内容阅读
目的:评估经尿道膀胱肿瘤切除术治疗膀胱癌的临床疗效。方法:选取2014年5月至2015年5月我院收治的54例膀胱癌患者,随机分成观察组和对照组,每组各27例,对照组实患者实施膀胱部分切除手术,观察组患者实施经尿道膀胱肿瘤切除术,观察治疗的临床效果。结果:两组患者的手术全部成功,观察组患者手术时间、术中出血量以及导尿时间和对照组相比存在明显的差异(P<0.05),有统计学意义;观察组并发症发生率为7.41%,对照组并发症发生率我18.52%,两组对比差异明显(P<0.05),有统计学意义。另外,两组患者在复发率方面相比没有明显的差异,无统计学意义。结论:经尿道膀胱肿瘤切除术治疗膀胱癌效果显著,可以有效的降低并发症发生率,值得临床推广。
Objective: To evaluate the clinical efficacy of transurethral resection of bladder tumor for bladder cancer. Methods: Fifty-four patients with bladder cancer admitted to our hospital from May 2014 to May 2015 were randomly divided into observation group and control group, with 27 cases in each group. The control group patients underwent partial bladder resection and the observation group patients Transurethral resection of the bladder tumor to observe the clinical effect of treatment. Results: The operation of both groups was successful. The operation time, intraoperative blood loss and catheterization time in the observation group were significantly different from those in the control group (P <0.05), and the complication rate in the observation group Was 7.41%, the incidence of complications in the control group was 18.52%, the difference was significant (P <0.05) between the two groups, with statistical significance. In addition, the two groups of patients in the recurrence rate compared to no significant difference, no statistically significant. Conclusion: Transurethral resection of the bladder tumor for bladder cancer has a significant effect, which can effectively reduce the incidence of complications and is worthy of clinical promotion.